PR

Prasad Ramakant Sagar

Active Director Director/Designated Partner DIN 11776495
DIN 11776495 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Prasad Ramakant Sagar

Prasad Ramakant Sagar is a Director/Designated Partner at Vexora Pharmaceuticals Private Limited (since 2026).

DIN 11776495
Primary Designation Director/Designated Partner
First Appointment 22 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director/Designated Partner22 Jul 20262026Active

Board colleagues of Prasad Ramakant Sagar

Directorship timeline

Open interactive timeline →
Vexora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prasad Ramakant Sagar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prasad Ramakant Sagar

Prasad Ramakant Sagar currently holds 1 directorship: Vexora Pharmaceuticals Private Limited (Director/Designated Partner, since 22 Jul 2026).

Prasad Ramakant Sagar was first appointed on 22 Jul 2026 as Director/Designated Partner at Vexora Pharmaceuticals Private Limited.

The current boards of Prasad Ramakant Sagar's companies include Siddhant Vijay Patil (Vexora Pharmaceuticals Private Limited), Sunanda Prasad Sagar (Vexora Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available